SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Björck E) ;lar1:(uu)"

Sökning: WFRF:(Björck E) > Uppsala universitet

  • Resultat 1-10 av 37
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Sedimbi, S. K., et al. (författare)
  • SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients
  • 2007
  • Ingår i: Genes Immun. - : Springer Science and Business Media LLC. - 1466-4879 .- 1476-5470. ; 8:6, s. 518-21
  • Tidskriftsartikel (refereegranskat)abstract
    • SUMO4 M55V, located in IDDM5, has been a focus for debate because of its association to type I diabetes (TIDM) in Asians but not in Caucasians. The current study aims to test the significance of M55V association to TIDM in a large cohort of Swedish Caucasians, and to test whether M55V is associated in those carrying human leukocyte antigen (HLA) class II molecules. A total of 673 TIDM patients and 535 age- and sex-matched healthy controls were included in the study. PCR-RFLP was performed to identify the genotype and allele variations. Our data suggest that SUMO4 M55V is not associated with susceptibility to TIDM by itself. When we stratified our patients and controls based on heterozygosity for HLA-DR3/DR4 and SUMO4 genotypes, we found that presence of SUMO4 GG increased further the relative risk conferred by HLA-DR3/DR4 to TIDM, whereas SUMO4 AA decreased the risk. From the current study, we conclude that SUMO4 M55V is associated with TIDM in association with high-risk HLA-DR3 and DR4, but not by itself.
  •  
3.
  • Shin, J. H., et al. (författare)
  • IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5
  • 2007
  • Ingår i: Genes Immun. - : Springer Science and Business Media LLC. - 1466-4879 .- 1476-5470. ; 8:6, s. 503-12
  • Tidskriftsartikel (refereegranskat)abstract
    • In a large case-control study of Swedish incident type I diabetes patients and controls, 0-34 years of age, we tested the hypothesis that the GIMAP5 gene, a key genetic factor for lymphopenia in spontaneous BioBreeding rat diabetes, is associated with type I diabetes; with islet autoantibodies in incident type I diabetes patients or with age at clinical onset in incident type I diabetes patients. Initial scans of allelic association were followed by more detailed logistic regression modeling that adjusted for known type I diabetes risk factors and potential confounding variables. The single nucleotide polymorphism (SNP) rs6598, located in a polyadenylation signal of GIMAP5, was associated with the presence of significant levels of IA-2 autoantibodies in the type I diabetes patients. Patients with the minor allele A of rs6598 had an increased prevalence of IA-2 autoantibody levels compared to patients without the minor allele (OR=2.2; Bonferroni-corrected P=0.003), after adjusting for age at clinical onset (P=8.0 x 10(-13)) and the numbers of HLA-DQ A1*0501-B1*0201 haplotypes (P=2.4 x 10(-5)) and DQ A1*0301-B1*0302 haplotypes (P=0.002). GIMAP5 polymorphism was not associated with type I diabetes or with GAD65 or insulin autoantibodies, ICA, or age at clinical onset in patients. These data suggest that the GIMAP5 gene is associated with islet autoimmunity in type I diabetes and add to recent findings implicating the same SNP in another autoimmune disease.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  • Antoniou, George A., et al. (författare)
  • European society for vascular surgery clinical practice guideline development scheme : an overview of evidence quality assessment methods, evidence to decision frameworks, and reporting standards in guideline development
  • 2022
  • Ingår i: European Journal of Vascular and Endovascular Surgery. - : Elsevier. - 1078-5884 .- 1532-2165. ; 63:6, s. 791-799
  • Forskningsöversikt (refereegranskat)abstract
    • Objective: A structured and transparent approach is instrumental in translating research evidence to health recommendations and evidence informed clinical decisions. The aim was to conduct an overview and analysis of principles and methodologies for health guideline development.Methods: A literature review on methodologies, strategies, and fundamental steps in the process of guideline development was performed. The clinical practice guideline development process and methodology adopted by the European Society for Vascular Surgery are also presented.Results: Sophisticated methodologies for health guideline development are being applied increasingly by national and international organisations. Their overarching principle is a systematic, structured, transparent, and iterative process that is aimed at making well informed healthcare choices. Critical steps in guideline development include the assessment of the certainty of the body of evidence; evidence to decision frameworks; and guideline reporting. The goal of strength of evidence assessments is to provide well reasoned judgements about the guideline developers’ confidence in study findings, and several evidence hierarchy schemes and evidence rating systems have been described for this purpose. Evidence to decision frameworks help guideline developers and users conceptualise and interpret the construct of the quality of the body of evidence. The most widely used evidence to decision frameworks are those developed by the GRADE Working Group and the WHO-INTEGRATE, and are structured into three distinct components: background; assessment; and conclusions. Health guideline reporting tools are employed to ensure methodological rigour and transparency in guideline development. Such reporting instruments include the AGREE II and RIGHT, with the former being used for guideline development and appraisal, as well as reporting.Conclusion: This guide will help guideline developers/expert panels enhance their methodology, and patients/clinicians/policymakers interpret guideline recommendations and put them in context. This document may be a useful methodological summary for health guideline development by other societies and organisations.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 37
Typ av publikation
tidskriftsartikel (35)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (34)
övrigt vetenskapligt/konstnärligt (3)
Författare/redaktör
Björck, Martin (31)
Wanhainen, Anders (9)
Ricco, Jean-Baptiste (7)
Venermo, M (6)
Beiles, B (6)
Kolh, Philippe (5)
visa fler...
Dick, Florian (5)
Chakfé, Nabil (5)
Tulamo, Riikka (5)
Wigger, P (5)
Menyhei, G. (5)
Dias, Nuno V. (4)
Aboyans, Victor (4)
Brodmann, Marianne (4)
De Carlo, Marco (4)
Venermo, Maarit (4)
De Borst, Gert J (4)
Coscas, Raphaël (4)
Kakkos, Stavros K. (4)
Trimarchi, Santi (4)
Vermassen, Frank (4)
Mani, Kevin (4)
Goncalves, Frederico ... (4)
Eckstein, Hans-Henni ... (3)
Naylor, Ross (3)
Sillesen, Henrik (3)
Bartelink, Marie-Lou ... (3)
Cohnert, Tina (3)
Collet, Jean-Philipp ... (3)
Czerny, Martin (3)
Espinola-Klein, Chri ... (3)
Kahan, Thomas (3)
Kownator, Serge (3)
Mazzolai, Lucia (3)
Roffi, Marco (3)
Sprynger, Muriel (3)
Tendera, Michal (3)
Tepe, Gunnar (3)
Vlachopoulos, Charal ... (3)
Desormais, Ileana (3)
Lindblad, B (3)
Twine, Christopher P (3)
Antoniou, George A. (3)
Mees, Barend M.E. (3)
Sigvant, Birgitta (3)
Boyle, Jonathan R. (3)
van den Berg, Jos C. (3)
Menyhei, Gabor (3)
Debus, E. Sebastian (3)
Thomson, I. A. (3)
visa färre...
Lärosäte
Göteborgs universitet (8)
Karolinska Institutet (6)
Umeå universitet (5)
Lunds universitet (5)
Linköpings universitet (4)
visa fler...
Örebro universitet (2)
Stockholms universitet (1)
Högskolan i Gävle (1)
Jönköping University (1)
Mittuniversitetet (1)
visa färre...
Språk
Engelska (36)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (27)
Naturvetenskap (2)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy